CEACAM 1,5,6,8 Antikörper
Der Maus Monoklonal Anti-CEACAM 1,5,6,8-Antikörper wurde für cELISA, FACS, IHC (fro), ELISA und WB validiert. Er ist geeignet, CEACAM 1,5,6,8 in Proben von Human zu detektieren. Es ist 1 Publikation verfügbar.
(1 reference)
Produktnummer ABIN108728
Kurzübersicht für CEACAM 1,5,6,8 Antikörper (ABIN108728)
Target
CEACAM 1,5,6,8 (CEACAM1/3/5/8)
(Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1/3/5/8 (CEACAM1/3/5/8))
Reaktivität
Human
Wirt
Maus
Klonalität
Monoklonal
Applikation
Cell-ELISA (cELISA), Flow Cytometry (FACS), Immunohistochemistry (Frozen Sections) (IHC (fro)), ELISA, Western Blotting (WB)
Klon
TET2
-
-
Spezifität
- Anti-human CEACAM1,5,6,8 (CD66a,b,c,e)
-
Aufreinigung
- Protein G
-
Immunogen
- immunisation with extracted protein of CEACAM5
-
Isotyp
- IgG2b
-
-
-
Applikationshinweise
-
Flow cytometry: 1 µg/10^6 cells
ELISA: 1:200 - 1:400
CELISA: 1:200 Western Blot: 4 µg/mL
Immunohistology: 1-2 µg/10^6 cells (on cryosections)
For each application a titration should be performed to determine the optimal concentration. -
Kommentare
-
Synonyms: CD66abce
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1 mg/mL
-
Buffer
- PBS, pH 7.2
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- short term: 2 °C - 8 °C, long term: -20 °C
-
-
-
: "Differential glycosylation of MUC1 and CEACAM5 between normal mucosa and tumour tissue of colon cancer patients." in: International journal of cancer. Journal international du cancer, (2011) (PubMed).
-
: "Differential glycosylation of MUC1 and CEACAM5 between normal mucosa and tumour tissue of colon cancer patients." in: International journal of cancer. Journal international du cancer, (2011) (PubMed).
-
- CEACAM 1,5,6,8 (CEACAM1/3/5/8) (Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1/3/5/8 (CEACAM1/3/5/8))
-
Andere Bezeichnung
- CEACAM1,5,6,8
-
Hintergrund
- TET2 was generated by immunisation with CEA partially purified from a perchloric acid extract from liver metastases of colonic tumors. TET2 is a broadly reactive antibody which reacts with most of the CEACAM molecules characterised to date.
-
UniProt
- P06731, P31997, P13688, P40199
Target
-
Sie sind hier:
